Loading organizations...

Low-cost blood glucose test strips scanned with a smartphone camera…
Key people at Simple Strips.
Simple Strips was founded in 2020 by Sam Kanawati (Founder).
Simple Strips developed a glucose monitoring system utilizing low-cost test strips readable by a smartphone camera. This technology integrated diagnostics directly into a user's mobile device, replacing traditional meters. The core offering provided an accessible, app-based method for individuals to efficiently track and manage blood sugar levels.
Founded by Sam Kanawati, Simple Strips emerged from the Y Combinator Winter 2020 batch. Kanawati's insight addressed the critical need for affordable and convenient diabetes management. The initiative sought to democratize access to vital health diagnostics by integrating smartphone technology into a streamlined monitoring process.
Simple Strips aimed to serve individuals requiring frequent glucose checks, particularly those seeking cost-effective, simplified alternatives. The company envisioned empowering people with diabetes through an integrated, less burdensome approach to health tracking. Its mission was to provide greater control over personal health data using innovative mobile diagnostic solutions.
Key people at Simple Strips.
Simple Strips was founded in 2020 by Sam Kanawati (Founder).
Simple Strips develops low-cost blood glucose test strips designed to be scanned using a smartphone camera, eliminating the need for expensive dedicated glucometers. Their product aims to make blood sugar monitoring more affordable and accessible, particularly for people managing diabetes or prediabetes. By leveraging smartphone technology, Simple Strips targets individuals who require frequent glucose testing but face cost barriers with traditional test strips and meters. This innovation addresses a critical healthcare need by reducing costs and simplifying the testing process, potentially expanding access to glucose monitoring globally. The company is in growth mode, focusing on scaling adoption and refining its smartphone-based testing technology[8].
Simple Strips was founded by Sam Kanawati (founding year not explicitly stated in available data) and is based in San Francisco, CA. The idea emerged from the recognition that conventional blood glucose testing remains costly due to the price of test strips and dedicated meters. By integrating test strip reading with ubiquitous smartphone cameras, Simple Strips aims to disrupt the traditional glucose monitoring market. Early traction includes participation in accelerator programs such as Y Combinator, which supports their development and go-to-market efforts[8].
Simple Strips rides the trend of digital health democratization and mobile health (mHealth), where smartphones become central platforms for health diagnostics. The timing is favorable due to the global rise in diabetes prevalence and increasing smartphone penetration worldwide. Market forces such as demand for affordable healthcare solutions and advances in smartphone camera and sensor technology support their approach. By reducing reliance on specialized medical devices, Simple Strips contributes to making chronic disease management more scalable and integrated into everyday technology ecosystems.
Looking ahead, Simple Strips is positioned to expand its market presence by refining its technology, securing regulatory approvals, and forming partnerships with healthcare providers or payers. Trends such as increasing telemedicine adoption and personalized health monitoring will likely accelerate demand for smartphone-based diagnostics. Their influence could grow as they demonstrate clinical accuracy and cost savings, potentially reshaping how glucose monitoring is delivered globally. Continued innovation and ecosystem building around smartphone health tools will be key to their sustained impact.
---
This summary synthesizes available information on Simple Strips, a startup innovating affordable glucose testing through smartphone integration, highlighting its mission, product, and strategic context. The company exemplifies the convergence of biotechnology and mobile technology to address a widespread health challenge.